Physical Exercise Prescription Program: Participants receive a structured and individualized 12-week program including:
Aerobic exercise (continuous and interval training, intensity guided by Borg scale)
Strength training using elastic bands (progressively increasing repetitions, series, and load)
Respiratory exercises with pressure-based devices
Flexibility exercises (static stretching routines)
Balance training (single-leg stance, heel-toe walking, eyes-closed tasks)
The program is generated through the MEDORA electronic system after baseline evaluation. A certified Exercise Technician provides instruction, supervision, and progression adjustments.
Study summary
This randomized controlled trial aims to evaluate the effectiveness of an individualized Physical Exercise Prescription Program delivered in Primary Care for adults aged 65 years and older. The intervention includes a structured assessment of physical fitness, muscle function and mass, physical activity level, and quality of life, followed by a tailored exercise plan encompassing aerobic, strength, respiratory, flexibility, and balance training. Outcomes will be compared with a control group receiving standard health advice to walk briskly for at least 30 minutes daily. The study also explores associations between polypharmacy, muscle function, physical performance, and quality of life.
Eligibility
Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Age ≥ 65 years
* Motivated to participate and able to provide informed consent
* Able to attend baseline assessment and follow-up
* Clinical stability allowing participation in exercise evaluation
Exclusion Criteria:
* Recent myocardial infarction
* Unstable angina
* Uncontrolled arrhythmias (symptomatic or hemodynamically compromising)
* Syncope
* Acute endocarditis, myocarditis, or pericarditis
* Severe or symptomatic aortic stenosis
* Uncontrolled heart failure
* Recent pulmonary thromboembolism or pulmonary infarction
* Lower-limb thrombosis
* Severe aortic stenosis or suspected dissecting aortic aneurysm
* Uncontrolled asthma
* Pulmonary edema
* Acute respiratory failure
* Acute non-cardiopulmonary illness that impairs exercise capacity (e.g., infection, thyrotoxicosis, acute renal failure)
* Mental disorder that prevents adequate cooperation.
Primary outcome measure(s)
Change in Quality of Life — Baseline to 3 months. Quality of Life will be measured by the SF-36 questionnaire. The SF-36 questionnaire is a widely used, patient-reported questionnaire measuring health-related quality of life. It uses points to assess health, with responses on Likert scales (e.g., 0 to 100) transformed into scores for 8 health domains: physical functioning, role limitations (physical/emotional), bodily pain, general health, vitality, social functioning, and mental health, where higher scores mean better health, ranging from 0 (maximum disability) to 100 (no disability).
Trial sites (1)
Facility
City
Region
Status
Centro de Salud de Villoria
Villoría
Salamanca
Recruiting
More Instituto de Investigación Biomédica de Salamanca trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
